1. What Is the Syringe Market?
The Syringe Market comprises needle-based drug delivery devices used to administer injectable medications in healthcare settings and at home across general-purpose, prefilled, safety-engineered, and speciality designs. The market includes conventional glass and plastic syringes, prefilled syringes for biological drugs, safety-engineered syringes with retractable needles, auto-injectors, and speciality syringes in varying barrel sizes. These devices deliver vaccines, biologics, GLP-1 therapies, anticoagulants, and oncology medications for hospitals, pharmacies, and patients requiring precise parenteral drug administration across clinical and home settings. Scope covers syringe devices for drug delivery and excludes infusion pumps, catheter systems, and needle-free drug delivery platforms classified separately under specialised drug administration device markets.
2. Syringe Market Size & Forecast
3. Emerging Technologies
- Polymer cyclic-olefin prefilled syringes are advancing for biologic and high-viscosity drug compatibility. Growing adoption in biologic and GLP-1 drug packaging is driven by chemical compatibility and stability needs.
- Auto-injector syringe platforms are emerging for patient self-administration of GLP-1 and biologic drugs. Increasing use in chronic disease self-injection is driven by patient convenience and home-administration demand.
- Safety-engineered syringes with retractable needles are expanding for healthcare-worker needlestick protection. Expanding adoption in hospital and clinical settings is driven by needlestick-injury regulations and safety mandates.
- Digital smart-syringe platforms are advancing for connected dose tracking and adherence monitoring programs. Growing integration in specialty drug programs enables real-time injection confirmation and dose data capture.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Industrial Automation Market.
4. Key Market Opportunity
A major opportunity in the Syringe Market is the GLP-1 therapy launch wave requiring large-scale prefilled syringe and auto-injector supply chains for once-weekly self-administered weight-loss and diabetes drugs. Semaglutide, tirzepatide, and other GLP-1 drug approvals have created exceptional demand for validated prefilled syringe and auto-injector primary packaging at pharmaceutical manufacturing scale, enabling competitive advantage for participants investing in this capability. Syringe manufacturers achieving pharmaceutical qualification for GLP-1 high-viscosity drug compatibility, supply at multi-billion unit volumes, and cycle-time-matched delivery can lock in long-term supply contracts, as industry stakeholders prioritise performance, efficiency, and compliance. GLP-1 drug manufacturers, contract fill-finish facilities, and pharmaceutical distributors benefit through validated primary packaging, reduced dose-preparation error, assured sterility, and patient-centric delivery formats, enabling competitive advantage for participants investing in this capability.
5. Top Companies in the Syringe Market
The following organisations hold leading positions in the Syringe Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Becton Dickinson
- B. Braun Melsungen
- SCHOTT Pharma
- Gerresheimer
- Terumo
- Hindustan Syringes
- Nipro
- Haselmeier
- Enable Injections
- West Pharmaceutical Services
- Stevanato Group
- SHL Medical
6. Market Segmentation
The Syringe Market is analysed across 6 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Product | Conventional Syringe Luer-Lock Conventional Syringe Luer-Slip Conventional Syringe Prefilled Syringe Glass Prefilled Syringe Polymer Prefilled Syringe COC Prefilled Syringe Safety Syringe Passive Safety Syringe Active Safety Syringe Auto-Injector Syringe Fixed-Dose Auto-Injector Variable-Dose Auto-Injector Low-Dead-Space Fixed-Needle Low-Dead-Space Detachable-Needle Low-Dead-Space |
| By Material | Glass Type I Borosilicate Glass Type II Surface-Treated Glass Polymer Polypropylene PP Syringe Cyclic Olefin Polymer COP Syringe Cyclic Olefin Copolymer |
| By Application | Vaccines Intramuscular Vaccine Syringe Subcutaneous Vaccine Syringe Intradermal Vaccine Syringe Biologics Monoclonal Antibody Delivery Biosimilar Delivery Anticoagulants GLP-1 Therapies GLP-1 Receptor Agonist Pen GLP-1 Prefilled Auto-Injector Oncology Cytotoxic Drug Syringe Biosimilar Oncology Syringe |
| By Volume | Below 1 mL 1-5 mL Above 5 mL |
| By End User | Hospitals and Clinics Retail Pharmacy Home Healthcare Immunisation Programs |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Syringe Market trajectory over the forecast period:
Biologic And GLP-1 Drug Adoption Is Driving Prefilled Syringe Demand.Large-molecule biologics, monoclonal antibodies, and GLP-1 weight-management therapies delivered in prefilled glass and polymer syringes are increasing demand for primary packaging containers from pharmaceutical manufacturers. SCHOTT Pharma and Gerresheimer expanded prefillable glass and polymer syringe programs through 2024 as pharmaceutical companies scaled GLP-1 and biologic launch volumes requiring validated primary packaging systems.
Safety-Syringe Regulations Are Reshaping Hospital Procurement Toward Retractable Devices.OSHA and EU needlestick-injury prevention directives requiring safety-engineered syringes in clinical settings are compelling hospitals to replace conventional syringes with retractable-needle and safety-shield devices. Becton Dickinson and B. Braun expanded safety-syringe programs through 2024 for hospital formulary conversions to retractable and passive-shield syringe devices mandated under occupational safety regulations.
Auto-Injector Platform Growth Is Broadening Patient Self-Administration Adoption.GLP-1 and biologic auto-injector pens pre-filled for once-weekly self-injection are increasing demand for combination syringe-device platforms that deliver high-viscosity drugs without healthcare professional support. Haselmeier and Enable Injections expanded auto-injector and wearable injector programs through 2024 for pharmaceutical companies launching GLP-1 and subcutaneous biologic therapies in patient-self-administration formats.
For related market intelligence, see the AI Quality Inspection Market.
8. Segmental Analysis
By product, conventional syringes dominated the Syringe Market in 2025, reflecting their dominant use across hospital medication preparation and general injection applications. Hospitals and clinics deploy conventional glass and plastic syringes at the highest unit volumes for routine medication administration, vaccine reconstitution, and infusion preparation across all clinical wards. Prefilled syringes are the fastest-growing product segment, fuelled by biologic, GLP-1, and vaccine launch volumes requiring validated ready-to-inject primary packaging for clinical and patient self-administration. Pharmaceutical manufacturers and fill-finish CMOs are specifying prefilled glass and polymer syringe systems for GLP-1 and biologic programmes at increasing volumes as self-injection adoption expands globally.
9. Regional Analysis
Regional demand patterns across the Syringe Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Syringe Market in 2025, with a market share of 39.0%. A large biologic, vaccine, and GLP-1 pharmaceutical industry and clinical hospital base is driving syringe demand among manufacturers and hospitals requiring high-volume injection device supply. Pharmaceutical companies and hospital formulary managers are increasing investment in prefilled and safety-syringe programs as biologic drug, GLP-1 therapy, and vaccine delivery volumes expand throughout the sector. Established hospital procurement, pharmacy distribution, and immunisation infrastructure is generating steady demand for safety and conventional syringes across diverse parenteral drug administration applications.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 11.50% during the forecast period. Expanding GLP-1 drug launches, biologic manufacturing scale-up, and hospital safety-syringe adoption are generating strong demand for syringes among fast-growing regional operators. Rising biologic and vaccine production and hospital safety-device mandates are encouraging manufacturers to deploy prefilled and retractable syringe programs across newly qualified regional pharmaceutical facilities. Growing immunisation programs and hospital drug administration are driving syringe demand across the wider region as parenteral drug volumes and safety-device adoption requirements expand quickly.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Syringe Market was valued at USD 19.97 Bn in 2025 and is projected to reach USD 42.31 Bn by 2034, growing at a CAGR of 8.70% over the 2026–2034 forecast period.
The Syringe Market is projected to grow at a CAGR of 8.70% from 2026 to 2034.
North America dominated the Syringe Market in 2025, with a market share of 39.0%.
The leading companies in the Syringe Market include Becton Dickinson, B. Braun Melsungen, SCHOTT Pharma, Gerresheimer, Terumo, Hindustan Syringes, Nipro, Haselmeier, Enable Injections, West Pharmaceutical Services, Stevanato Group, SHL Medical.
Biologic and glp-1 drug adoption is driving prefilled syringe demand.
By product, conventional syringes dominated the Syringe Market in 2025, reflecting their dominant use across hospital medication preparation and general injection applications.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.